Using Big Data to Personalize the Healthcare Experience: Clinical Trials and Cancer

How Big Data is Changing Current Research Methodology: Cancer Cancer is the second leading cause of death in the United States. Current treatments are ineffective with over 75% of patients not responding to treatments, despite the $50 billion pharmaceutical companies…

The Role of Big Data Personalizing the Healthcare Experience: Genomics

  Genomics is making headlines in both academia and the celebrity world.  When genetic tests revealed that Angelina Jolie was predisposed to breast cancer, intense media cover ensued. Since then, genetic testing and genomics have been propelled to the front of…

A Dentist’s Thoughts on Salivary Diagnostics

             Salivary diagnostics may be a cheaper, faster and better way to diagnose certain diseases. Already effective in oral cancer and Sjogren's syndrome, researchers are looking to expand the potential of using saliva. Blood tests…

(Part 3) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Three: Election Day special: Regulatory Obstacles (continued from Part Two) By Ellen Martin Here is a 352-page description of US healthcare regulation as of 2006: Robert I. Field’s Health Care Regulation in America: Complexity, Confrontation, and Compromise. It is always mind…

(Part 2) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part Two: Healthcare Structural Issues (continued from Part One) By Ellen Martin First, let’s recognize the fundamental market disconnect between providers, patients and third-party payers like employers, insurance companies, and managed care. This detachment is a fundamental reason as to why…

(Part 1) The Data “Revolution” in Healthcare: Obstacles and Opportunities

Part One: Introduction By Ellen Martin As evidenced by StrataRx, as well as our Hype and Hope white paper, expectations run high regarding data’s potential to transform healthcare: lower costs, fewer errors, and better patient outcomes. So high, indeed, as…

0